INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

8,832 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
44
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$1.18M
24.4K sh
Sep 2, 2026Sep 4, 2026
Page 43 of 221
← PrevNext →
traded Sep 2, 2026
+2d
SEC Form 4

Evidence

43
Gilbert Ray Cisneros, Jr.DSelf
SFMSprouts Farmers Market, Inc.
Purchase
BUY$15K – $50KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

43
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$52K
1,990 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
APPAppLovin Corp
Purchase
BUY$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
EAElectronic Arts Inc. - Common Stock
Partial sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
PLTRPalantir Technologies Inc.
Purchase
BUY$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
AVAVAeroVironment Inc
Sale
SELL$1,001 – $15KJul 2, 2026Sep 4, 2026
traded Jul 2, 2026
+64dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
LITELumentum Holdings Inc.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
DDDuPont de Nemours, Inc.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
Gilbert Ray Cisneros, Jr.DSelf
VZVERIZON COMMUNICATIONS INC
Partial sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

42
WA
Ware J. AnthonyDirector
TRAXFirst Tracks Biotherapeutics, Inc.
Open-market sale
SELL$1.76M
39.3K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

41
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$511K
10.6K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

41
Gilbert Ray Cisneros, Jr.DSelf
STZCONSTELLATION BRANDS, INC.
Sale
SELL$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

41
Gilbert Ray Cisneros, Jr.DSelf
BABAAlibaba Group Holding Ltd
Sale
SELL$100K – $250KJul 24, 2026Sep 4, 2026
traded Jul 24, 2026
+42dHouse PTR

Evidence

41
LA
Lacerte Rene A.Director, CEO
BILLBILL Holdings, Inc.
Open-market sale
SELL$565K
11.8K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

41
DA
De Angoitia AlfonsoDirector
LILALiberty Latin America Ltd.
Open-market purchase
BUY$363K
17.6K sh
Sep 1, 2026Sep 4, 2026
traded Sep 1, 2026
+3dSEC Form 4

Evidence

40
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$46K
1,738 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

40
Gilbert Ray Cisneros, Jr.DSelf
NVDANVIDIA CORP
Purchase
BUY$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

40
Gilbert Ray Cisneros, Jr.DSelf
ACNAccenture plc
Purchase
BUY$1,001 – $15KJul 17, 2026Sep 4, 2026
traded Jul 17, 2026
+49dHouse PTR

Evidence

40
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$133K
5,130 sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

40
Gilbert Ray Cisneros, Jr.DSelf
HQYHEALTHEQUITY, INC.
Purchase
BUY$1,001 – $15KJul 10, 2026Sep 4, 2026
traded Jul 10, 2026
+56dHouse PTR

Evidence

40
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Open-market sale
SELL$786K
136.3K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence

40
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$118K
4,481 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

40
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$1.87M
8,277 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
FERGFerguson Enterprises Inc. /DE/
Purchase
BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

39
TB
Turner Matthew BakerPRES., PATIENT AFFORDABILITY
PAYSPaysign, Inc.
Open-market sale
SELL$63K
15.1K sh
Feb 3, 2026Sep 4, 2026
traded Feb 3, 2026
+213dSEC Form 4

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
USPHU S PHYSICAL THERAPY INC /NV
Purchase
BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
SFSTIFEL FINANCIAL CORP
Purchase
BUY$1,001 – $15KJul 10, 2026Sep 4, 2026
traded Jul 10, 2026
+56dHouse PTR

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
BCPCBALCHEM CORP
Purchase
BUY$1,001 – $15KJul 10, 2026Sep 4, 2026
traded Jul 10, 2026
+56dHouse PTR

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
BCRXBIOCRYST PHARMACEUTICALS INC
Purchase
BUY$1,001 – $15KJul 10, 2026Sep 4, 2026
traded Jul 10, 2026
+56dHouse PTR

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
COMPCompass, Inc.
Purchase
BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

39
LS
Landesberg StuartDirector
GROVGrove Collaborative Holdings, Inc.
Open-market purchase
BUY$5,542
5,384 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

39
CK
Cunningham Bradley KramerChief Technology Officer
PAYSPaysign, Inc.
Open-market sale
SELL$73K
10.0K sh
May 29, 2026Sep 4, 2026
traded May 29, 2026
+98dSEC Form 4

Evidence

39
Gilbert Ray Cisneros, Jr.DSelf
AORTARTIVION, INC.
Purchase
BUY$1,001 – $15KJul 16, 2026Sep 4, 2026
traded Jul 16, 2026
+50dHouse PTR

Evidence

38
NT
Notman TaliCHIEF REVENUE OFFICER
FROGJFrog Ltd
Open-market sale
SELL$1.73M
19.2K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

38
SA
Shauli AviChief Technology Officer
RSKDRISKIFIED LTD.
Open-market sale
SELL$193K
30.0K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

38
PA
Pollitzer AdamDirector, Chief Executive Officer
NMIHNMI Holdings, Inc.
Open-market sale
SELL$7.75M
172.7K sh
Sep 4, 2026Sep 4, 2026
traded Sep 4, 2026
+0dSEC Form 4

Evidence

36
CP
Courtney PhillipsGC and Corp. Secretary
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$6,590
243 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale
SELL$37K
1,375 sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC Form 4

Evidence

36
SJ
Simon JoshDirector, Chief Executive Officer
FNKOFunko, Inc.
Open-market sale
SELL$267K
45.5K sh
Sep 3, 2026Sep 4, 2026
traded Sep 3, 2026
+1dSEC Form 4

Evidence